Browse by category

Results from the ESSENCE Phase III clinical trial show treating patients with semaglutide can halt and even reverse liver disease, the...

Novo Nordisk has announced that the FDA accepted its New Drug Application (NDA) submission for an investigational once-daily, 25mg oral...

A recent analysis of the SURPASS-3 trial indicates that decreases in muscle volume with tirzepatide largely followed the overall...

The novel classification of diabetes risk subtypes can help to identify people who benefit particularly greatly from bariatric surgery,...

Simultaneous liver transplant surgery and concurrent sleeve gastrectomy (LTSG) for patients living with severe obesity is safe and...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

There are no significant differences in rates of 30-day serious complications between endoscopic sleeve gastroplasty (ESG) and...

The use of opioid-free anaesthesia (OFA) reduces post-bariatric surgical morphine consumption and improves pain management without...

Tirzepatide decreased participants’ calorie intake at lunch/dinner by reducing appetite while increasing fat oxidation, thus helping...

In the past 20 years, the average rate of obesity among adults in the US has risen by approximately 30%, but the rate of those with the...